首页> 外国专利> PHARMACEUTICAL COMPOSITION OF SODIUM PENTABORATE FOR INCREASING THE RESPONSE OF PRE-ACTIVATED T LYMPHOCYTES AND NK CELLS IN IMMUNOCOMPETENT INDIVIDUALS.

PHARMACEUTICAL COMPOSITION OF SODIUM PENTABORATE FOR INCREASING THE RESPONSE OF PRE-ACTIVATED T LYMPHOCYTES AND NK CELLS IN IMMUNOCOMPETENT INDIVIDUALS.

机译：戊酸钠的药物成分，可提高免疫原性个体中预活化的T淋巴细胞和NK细胞的反应。

页面导航

摘要
著录项
相似文献

摘要

The invention relates to a pharmaceutical composition comprising an effective quantity of an immunomodulating agent, such as a pentaborate compound and/or its pharmaceutically acceptable salts and/or hydrates and/or crystalline forms, for increasing the immune response of pre-activated cytotoxic T-lymphocytes CD8+, T-helper cells CD4+, and NK cells, in an unexpected manner, for the treatment of viral diseases (not including human immunodeficiency virus infection), bacterial diseases and protozoan diseases. The invention also promotes cell death induction of the body's own cells that are altered and/or stressed in a viral infection (not including human immunodeficiency virus infection), bacterial infection and protozoan infection, as a self-regulating mechanism.

机译：本发明涉及药物组合物，其包含有效量的免疫调节剂，例如五硼酸酯化合物和/或其药学上可接受的盐和/或水合物和/或结晶形式，用于增加预活化的细胞毒性T-蛋白的免疫应答。淋巴细胞CD8 +，T辅助细胞CD4 +和NK细胞以意想不到的方式用于治疗病毒性疾病（不包括人类免疫缺陷病毒感染），细菌性疾病和原生动物疾病。本发明还促进在病毒感染（不包括人免疫缺陷病毒感染），细菌感染和原生动物感染中改变和/或应激的人体自身细胞的细胞死亡诱导，作为自我调节机制。

著录项

公开/公告号MX2017008611A

专利类型
公开/公告日2019-02-08

原文格式PDF
申请/专利权人 JUAN PABLO GALVÁN PÉREZ;
展开▼

申请/专利号MX20170008611
发明设计人 GABRIEL MARCELÍN JIMÉNEZ;ALIONKA CITLALI P. ANGELES MORENO;RAMÓN SOTO VÁZQUEZ;PATRICIA PARRA CERVANTES;JUAN PABLO GALVÁN PÉREZ;OCTAVIO RODRÍGUEZ CORTÉS;FELIX LUGO TREJO;
展开▼

申请日2017-06-28
分类号A61K33/22;A61P31/04;A61P31/12;A61P33/02;A61P37/04;
国家 MX
入库时间 2022-08-21 12:02:01

相似文献

专利
外文文献
中文文献